In hepatocellular carcinoma (HCC), RBM47 upregulation significantly inhibits tumor progression in vitro, primarily through the upregulation of UPF1, serving as a tumor suppressor by acting as a DNA/RNA binding protein at both transcriptional and post-transcriptional levels (47). Here, UPF1 is linked to neoplasm.